论文部分内容阅读
Objective: To evaluate the response and survival rates of refractory or relapsed Hodgkins lyrnphoma (HL) patients treated with autologous peripheral blood stem cell transplantation(APBSCT).Methods: Thirty HL patients were analyzed retrospectively from January 2004 to August 2012.A statistical analysis was performed to explore the long term outcomes and prognostic factors of patients treated with APBSCT.The median age of all of the patients at the time of the transplant was 30 years (13 to55 years).Patients had major nodular sclerosis HL and were in stage Ⅲ/Ⅳ.